Cardiovascular and Interventional Radiological Society of Europe

September 10-14 | Barcelona, Spain

Science for people

September 10-14 | Barcelona, Spain

Science for people

September 10-14 | Barcelona, Spain

September 10-14 | Barcelona, Spain

September 10-14 | Barcelona, Spain

Science for people
Slider
ProgrammeCIRSE meetsCIRSE meets EASL

CIRSE meets EASL

Locoregional therapies in liver cancer – where do they fit in the bigger picture?

Sunday, September 11, 2022, 11:30-12:30 CEST

Moderators: M. Reig (Barcelona/ES), T. Kroencke (Augsburg/DE)

Introduction
M. Reig (Barcelona/ES), T. Kroencke (Augsburg/DE)

Therapeutic sequence and stage migration: how can the new BCLC classification give guidance?
M. Reig (Barcelona/ES)

Combining transarterial therapies with immunotherapy – update on current trials
D.J. Pinato (London/GB)

Where is the place of TACE in intermediate state hepatocellular cancer in 2022?
M. Ronot (Paris/FR)

Radiation segmentectomy in curative intent – already a game changer?
J. Ricke (Munich/DE)

Closing remarks
J.C. Nault (Paris/FR), T. Kroencke (Augsburg/DE)

About EASL

EASL, The European Association for the Study of the Liver, is a medical association dedicated to pursuing excellence in liver research, to the clinical practice of liver disorders, and to providing education to all those interested in hepatology. While the roots of the association were founded in Europe in 1966, EASL continues to engage globally with all stakeholders in the liver field wherever they are based. Throughout our strategic directions defined around Science, Education and Advocacy, our aim is to spread knowledge and expertise in best practices and the latest scientific breakthroughs in hepatology.